Juno Therapeutics (NASDAQ:JUNO)

CAPS Rating: 5 out of 5 99.43

Caps

How do you think JUNO will perform against the market?

Add Stock to CAPS Watchlist

All Players

111 Outperform
1 Underperform
 

All-Star Players

28 Outperform
0 Underperform
 

Wall Street

1 Outperform
0 Underperform
 

Top JUNO Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Breq (73.97)
Submitted July 19, 2016

One has to have a strong stomach to hold this one right now. They have quite a few irons in the fire and despite the recent set backs the companies therapies are quite promising. Mentally this is in my lottery ticket part of my portfolio.

SkepBioInvestor (< 20)
Submitted April 04, 2015

Risky red thumb for one of the most loved biotech companies in the hottest field of the moment. But cytokine storm doesn't sound too well, does it?

JUNO VS S&P 500 (SPY)

JUNO Summary

Recent Community Commentary

Read the most recent pitches from players about JUNO.

Recs

0
Member Avatar tavo2311 (70.92) Submitted: 1/21/2018 7:19:27 PM : Outperform Start Price: $86.27 JUNO Score: +1.78

Was already a fan of Juno before this week when it spiked big on rumors of a takeover bid being prepared by Celgene. Juno can command a premium, even to what the market is pricing in now post rumors. Picking Juno now with the comfort that 1) it gets purchased by another company I'm a fan of - Celgene, or 2) i'm just as comfortable with the long term outlook of Juno on its own.

Recs

0
Member Avatar ryonjarvis (86.30) Submitted: 12/15/2017 4:28:29 PM : Outperform Start Price: $44.96 JUNO Score: +89.94

Motley Fool Explorer 2018, 1 of 4 Biotech plays.

Recs

0
Member Avatar just10 (< 20) Submitted: 7/26/2016 3:27:48 PM : Outperform Start Price: $30.51 JUNO Score: +156.94

Has a deal with Celgene.

Leaderboard

Find the members with the highest scoring picks in JUNO.

Score Leader

ooker1441

ooker1441 (47.05) Score: +351.09

The Score Leader is the player with the highest score across all their picks in JUNO.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
stereotyp72 67.27 1/24/2017 Outperform 5Y $19.62 +343.22% +22.54% +320.69 0 Comment
JimAnder 59.06 12/7/2016 Outperform 5Y $19.63 +343.00% +25.23% +317.76 0 Comment
bigongit1 67.14 12/7/2016 Outperform 5Y $19.63 +343.00% +25.23% +317.76 0 Comment
freneyjohn < 20 1/27/2017 Outperform 5Y $20.01 +334.58% +20.92% +313.66 0 Comment
RUNNER71 70.22 11/29/2016 Outperform 1Y $22.00 +295.27% +25.80% +269.47 0 Comment
jyurow 69.14 6/8/2017 Outperform 5Y $22.70 +283.08% +13.80% +269.28 0 Comment
Irishbetter 96.39 3/13/2017 Outperform 5Y $23.20 +274.83% +16.75% +258.08 0 Comment
giant123 92.00 8/15/2017 Outperform 5Y $28.51 +205.02% +12.32% +192.69 0 Comment
dollarsandcents1 < 20 2/2/2016 Outperform 5Y $25.75 +237.71% +45.07% +192.64 0 Comment
Breq 73.97 7/19/2016 Outperform 5Y $27.73 +213.65% +28.50% +185.15 1 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackJimCramer 85.33 6/14/2016 Outperform 3W $41.06 +111.79% +33.35% +78.44 0 Comment
Anonymous331 36.65 12/15/2015 Outperform 5Y $46.22 +85.43% +39.13% +46.31 1/29/2018 @ $85.70 0 Comment
TrackJimCramer 85.33 12/9/2015 Underperform 3W $46.71 -12.10% +1.31% +13.41 6/14/2016 @ $41.06 0 Comment
Anonymous331 36.65 8/24/2015 Outperform 5Y $33.57 +58.83% +9.36% +49.47 10/29/2015 @ $53.32 0 Comment
TrackJimCramer 85.33 6/3/2015 Outperform 3W $57.22 -18.37% -3.10% -15.26 12/9/2015 @ $46.71 0 Comment
TrackJimCramer 85.33 2/12/2015 Underperform 3W $40.34 +41.84% +1.44% -40.41 6/3/2015 @ $57.22 0 Comment
TrackJimCramer 85.33 12/19/2014 Outperform 3W $35.00 +15.26% +1.16% +14.10 2/12/2015 @ $40.34 0 Comment

Advertisement